(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of 361.78% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.03%.
Nautilus Biotechnology's revenue in 2026 is $190,000.On average, 5 Wall Street analysts forecast NAUT's revenue for 2026 to be $71,173,464, with the lowest NAUT revenue forecast at $62,355,059, and the highest NAUT revenue forecast at $86,183,600. On average, 5 Wall Street analysts forecast NAUT's revenue for 2027 to be $698,376,664, with the lowest NAUT revenue forecast at $491,586,926, and the highest NAUT revenue forecast at $988,773,083.
In 2028, NAUT is forecast to generate $2,644,745,300 in revenue, with the lowest revenue forecast at $2,113,836,509 and the highest revenue forecast at $3,180,108,023.